A research group at Uppsala University has developed a simple and effective artificial blood-brain barrier model that can be used to determine how well antibody-based therapies can enter the brain. Today animal experimentation ...
Feb 24, 2023
0
50
High doses of the drug ivermectin, controversially recommended by some high-profile political and media figures during the COVID-19 pandemic, is ineffective at treating the COVID-19 virus, say University of Oxford- affiliated ...
Feb 22, 2023
1
69
Building a new precision cancer treatment comes with no shortage of scientific challenges. Now, a group of University of Florida researchers have made a significant discovery in the effort to develop potent, highly targeted ...
Feb 20, 2023
0
68
The original vaccinations for COVID-19 induce potent antibodies that protect against SARS-CoV-2.
Feb 15, 2023
1
137
A new class of SARS-CoV-2 antibodies has been shown to neutralize multiple variants of the virus, providing hope for a better antiviral medication to prevent and treat COVID-19 symptoms in at-risk individuals, according to ...
Feb 14, 2023
0
30
Researchers at The University of Texas MD Anderson Cancer Center have identified CD70 as being highly expressed on drug-resistant cancer cells in EGFR-mutant non-small cell lung cancer (NSCLC), highlighting a novel therapeutic ...
Feb 13, 2023
0
38
An allergen-specific inhibitor devised by researchers at the University of Notre Dame and the Indiana University School of Medicine has successfully prevented potentially life-threatening allergic responses to peanuts.
Feb 8, 2023
0
174
An international research team has provided one of the first real-world estimates of vaccine effectiveness against omicron infections, irrespective of symptoms or severity. From a serological survey of 5,310 blood donors ...
Feb 7, 2023
4
128
Sometimes in science, "Eureka!" moments happen with surprisingly little effort. Sometimes they take years or decades to emerge. Such was the case with Brian Kraemer's research team and their recent study of the protein tau ...
Feb 6, 2023
0
47
Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved treatment for Zaire ebolavirus (Ebola virus).
Jan 30, 2023
0
47
